Hand and Foot Skin Reaction

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hand and Foot Skin Reaction trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04979078

Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction

Hand-foot syndrome (HFS) is a side effect of chemotherapy. HFS is characterized by redness, swelling, and pain on the palms of the hands and/or soles of the fee…

Belgium40 participantsStarted 2022-01-12

Treatment: Photobiomodulation therapy (PBMT)

All recent trials (8 shown)

CompletedNot Applicable

NCT06856590

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

This study aims to evaluate whether a combination of oral zinc supplementation and transdermal clobetasol cream is effective in preventing and reducing the seve…

Turkey (Türkiye)150 participantsStarted 2025-02-20

Treatment: Zinc Supplementation, Clobetasol Propionate 0.05% Cream

UnknownPhase 2

NCT04088318

A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

Hand-Foot Skin Reaction (HFSR) is a common adverse event induced by Vascular Endothelial Growth Receptor Inhibitor (VEGFRi) treatment in cancer patients. The ma…

United States170 participantsStarted 2019-12-09

Treatment: OQL011, Vehicle Ointment

Hand and Foot Skin Reaction

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction

All recent trials (8 shown)

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction

All recent trials (8 shown)

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

Efficacy of Extra Virgin Olive Oil (EVOO) Supplementation on Hand-Foot Syndrome Incidence in Patients With Capecitabine

Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105

Prevention of Hand-foot Skin Reaction

The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction

Sorafenib-induced Hand- Foot Skin Reaction Treatment